Literature DB >> 19796777

Should triglycerides and the triglycerides to high-density lipoprotein cholesterol ratio be used as surrogates for insulin resistance?

Su-Jong Kim-Dorner1, Patricia A Deuster, Stacey A Zeno, Alan T Remaley, Merrily Poth.   

Abstract

The aims of the present study were to examine whether triglycerides (TG) and the triglyceride to high-density lipoprotein cholesterol ratio (TG/HDL-C) could predict insulin resistance in healthy African Americans and whites. This cross-sectional study included 99 African American and 50 white men and women between 18 and 45 years of age with body mass indexes between 18.5 and 38.0 kg/m(2). Anthropometric measures were obtained; and overnight fasting blood was collected for TG, HDL-C, glucose, and insulin. Insulin resistance was defined by fasting insulin concentration of at least 13.13 microU/mL and homeostasis model assessment of insulin resistance (HOMA-IR) of at least 2.5. Receiver operating characteristic curves were used to analyze the data. African Americans and whites had comparable demographic and anthropometric measures. Fasting insulin was higher in African Americans (12.4 +/- 7.8 microU/mL) than whites (10.2 +/- 7.5 microU/mL), but HOMA-IR did not differ significantly (African Americans, 2.9 +/- 2.0; whites, 2.4 +/- 1.9). Triglycerides and TG/HDL-C were significantly lower in African Americans (TG, 68.2 +/- 43.3 mg/dL; TG/HDL-C, 1.8 +/- 2.1) compared with whites (TG, 105.4 +/- 55.2 mg/dL; TG/HDL-C, 2.8 +/- 1.8). Area under the receiver operating characteristic curves revealed that both TG and TG/HDL-C were acceptable markers of insulin resistance, as defined by fasting insulin concentration, in whites, 0.770 and 0.765, respectively, but poor predictors in African Americans, 0.633 and 0.651, respectively. Similarly, TG and TG/HDL-C were acceptable in predicting insulin resistance, as measured by HOMA-IR, in whites, 0.763 and 0.770, respectively, but poor in predicting HOMA-IR in African Americans, with areas of 0.625 and 0.639, respectively. In conclusion, the relationship between TG and TG/HDL-C with insulin resistance differs by ethnicity; and using TG and TG/HDL-C to predict insulin resistance in African Americans would not be appropriate. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19796777     DOI: 10.1016/j.metabol.2009.07.027

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  63 in total

1.  Relation of uric acid to serum levels of high-sensitivity C-reactive protein, triglycerides, and high-density lipoprotein cholesterol and to hepatic steatosis.

Authors:  Tanya Keenan; Michael J Blaha; Khurram Nasir; Michael G Silverman; Rajesh Tota-Maharaj; Jose A M Carvalho; Raquel D Conceição; Roger S Blumenthal; Raul D Santos
Journal:  Am J Cardiol       Date:  2012-09-10       Impact factor: 2.778

2.  Use of the triglyceride to HDL cholesterol ratio for assessing insulin sensitivity in overweight and obese children in rural Appalachia.

Authors:  Kristie Grove Bridges; Traci Jarrett; Anthony Thorpe; Adam Baus; Jill Cochran
Journal:  J Pediatr Endocrinol Metab       Date:  2016-02       Impact factor: 1.634

3.  Comparison of insulin sensitivity measures in South Asians.

Authors:  Subbulaxmi Trikudanathan; Annaswamy Raji; Bindu Chamarthi; Ellen W Seely; Donald C Simonson
Journal:  Metabolism       Date:  2013-07-29       Impact factor: 8.694

4.  Low HDL-Cholesterol with Normal Triglyceride Levels is the Most Common Lipid Pattern in West Africans and African Americans with Metabolic Syndrome: Implications for Cardiovascular Disease Prevention.

Authors:  Anne E Sumner; Jie Zhou; Ayo Doumatey; Omoye E Imoisili; Albert Amoah; Joseph Acheampong; Johnnie Oli; Thomas Johnson; Clement Adebamowo; Charles N Rotimi
Journal:  CVD Prev Control       Date:  2010-09-01

5.  The triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio as a predictor of insulin resistance, β-cell function, and diabetes in Hispanics and African Americans.

Authors:  Kendra A Young; Amita Maturu; Carlos Lorenzo; Carl D Langefeld; Lynne E Wagenknecht; Yii-Der I Chen; Kent D Taylor; Jerome I Rotter; Jill M Norris; Neda Rasouli
Journal:  J Diabetes Complications       Date:  2018-11-03       Impact factor: 2.852

6.  Racial/ethnic differences in the association of triglycerides with other metabolic syndrome components: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Susan Xiaoqin Lin; Mercedes Carnethon; Moyses Szklo; Alain Bertoni
Journal:  Metab Syndr Relat Disord       Date:  2010-10-19       Impact factor: 1.894

7.  Reducing vascular events risk in patients with dyslipidaemia: an update for clinicians.

Authors:  Michel P Hermans; Jean-Charles Fruchart
Journal:  Ther Adv Chronic Dis       Date:  2011-09       Impact factor: 5.091

8.  Triglyceride-based screening tests fail to recognize cardiometabolic disease in African immigrant and African-American men.

Authors:  Sophia S K Yu; Natalie L M Ramsey; Darleen C Castillo; Madia Ricks; Anne E Sumner
Journal:  Metab Syndr Relat Disord       Date:  2012-12-05       Impact factor: 1.894

9.  Plasma triglyceride/HDL-cholesterol ratio, insulin resistance, and cardiometabolic risk in young adults.

Authors:  Miguel Murguía-Romero; J Rafael Jiménez-Flores; Santiago C Sigrist-Flores; Miguel A Espinoza-Camacho; Mayra Jiménez-Morales; Enrique Piña; A René Méndez-Cruz; Rafael Villalobos-Molina; Gerald M Reaven
Journal:  J Lipid Res       Date:  2013-07-17       Impact factor: 5.922

10.  NON-INVASIVE ASSESSMENT OF LIVER STEATOSIS AND FIBROSIS USING TRANSIENT ELASTOGRAPHY AND CONTROLLED ATTENUATION PARAMETER IN TYPE 2 DIABETES PATIENTS.

Authors:  A Sima; I Sporea; R Timar; M Vlad; A Braha; A Popescu; S Nistorescu; R Mare; R Sirli; A Albai; O Albai; L Diaconu; T Sorescu; S Popescu; L Sima
Journal:  Acta Endocrinol (Buchar)       Date:  2018 Jul-Sep       Impact factor: 0.877

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.